AI could help decide best treatment for ovarian cancer

NCT ID NCT06017557

Recruiting now Diagnosis Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tests whether artificial intelligence (AI) can analyze videos from a keyhole surgery (laparoscopy) to predict if ovarian cancer tumors can be completely removed. The goal is to help doctors choose the best treatment plan—surgery first or chemotherapy first—for each patient. About 151 women with advanced ovarian cancer will take part.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Artificial intelligence (AI) and machine learning software
What this could lead to: If successful, this could lead to a more accurate, automated way to decide whether ovarian cancer patients should have surgery first or chemotherapy first, improving treatment outcomes.
What could go wrong: This is a small pilot study, so the AI model may not be accurate enough yet. The results may not apply to all hospitals or patients, and the technology needs further validation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OVARIAN CANCER STAGE III are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ovarian cancer ovarian carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OVARIAN CANCER STAGE III OVARIAN CANCER STAGE IV

Contacts and locations

Locations

Fondazione Policlinico Universitario A. Gemelli IRCCS, UOC Ginecologia Oncologica
RECRUITING

Roma, 00168, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.